Abstract
Dehydroepiandrosterone (DHEA) and its sulfated ester (DHEAS) are two of the most abundant steroid hormones in the human circulation. Like cortisol, they are produced by the adrenal cortex and released into the circulation in a circadian pattern. Although the exact physiological roles of DHEA(S) are unclear, some of their actions may stem from intracrine conversion of DHEA(S) to estradiol within specific tissues, including cognitive brain centers. Importantly, circulating DHEA(S) concentrations decrease markedly during aging, and this decrease has been implicated in the cause of age-associated cognitive decline. However, although correlations have been demonstrated between circulating DHEA(S) concentrations and cognitive ability in certain human patient populations, such correlations have yet to be convincingly demonstrated during normal aging. Furthermore, despite DHEA being widely available in the United States, as a food supplement, there is little evidence supporting the view that physiological doses of exogenous DHEA can improve cognitive function in the elderly.
Original language | English (US) |
---|---|
Title of host publication | Assessments, Treatments and Modeling in Aging and Neurological Disease |
Subtitle of host publication | The Neuroscience of Aging |
Publisher | Elsevier |
Pages | 269-278 |
Number of pages | 10 |
ISBN (Electronic) | 9780128180006 |
DOIs | |
State | Published - Jan 1 2021 |
Keywords
- Adrenalsteroids
- Caloric restriction
- Circadian
- Cognitive decline
- Cortisol
- Dehydroepiandrosterone
- Hormone replacement
- Intracrinology
- Menopause
- Neurosteroidogenesis
ASJC Scopus subject areas
- General Medicine
- General Neuroscience